niacinamide has been researched along with Bone Hypertrophy in 1 studies
nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment with niacinamide and acetazolamide decreased TmP/GFR and serum phosphate, which was paralleled by a decrease in serum C-terminus FGF23." | 1.35 | A case of familial tumoral calcinosis/hyperostosis-hyperphosphatemia syndrome due to a compound heterozygous mutation in GALNT3 demonstrating new phenotypic features. ( Brahim, J; Collins, MT; Dumitrescu, CE; Farrow, EG; Hart, TC; Kelly, MH; Khosravi, A; Murphey, MD; Nathan, MH; White, KE, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dumitrescu, CE | 1 |
| Kelly, MH | 1 |
| Khosravi, A | 1 |
| Hart, TC | 1 |
| Brahim, J | 1 |
| White, KE | 1 |
| Farrow, EG | 1 |
| Nathan, MH | 1 |
| Murphey, MD | 1 |
| Collins, MT | 1 |
1 other study available for niacinamide and Bone Hypertrophy
| Article | Year |
|---|---|
A case of familial tumoral calcinosis/hyperostosis-hyperphosphatemia syndrome due to a compound heterozygous mutation in GALNT3 demonstrating new phenotypic features.
Topics: Acetazolamide; Adult; Calcinosis; Child; Diuretics; Female; Fibroblast Growth Factor-23; Fibroblast | 2009 |